DeepVerge has announced its unaudited interim results for the six months ended 30 June 2021. Once again delivering on best financial expectations, H1 2021 revenues expanded by 231% to £3.319m
DeepVerge has announced its unaudited interim results for the six months ended 30 June 2021. Once again delivering on best financial expectations, H1 2021 revenues expanded by 231% to £3.319m
DeepVerge and Ion Exchange announce India Centre of Excellence for Modern Water All Membrane Brine Concentration (“AMBC”)
DeepVerge collaborate with Microsaic Systems plc to launch a range of miniature mass spectrometers with triple quadrupole limits of detection for organic chemical analysis in water and soil
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces that its wholly-owned subsidiary, ProBiotix Health Ltd, has extended
DeepVerge’s AGM of 26 July 2021 provided its Board with an ideal platform to highlight both the Group’s transformational past year and the exceptional opportunities it now has to deliver
Updates on Microtox® PD wastewater project
£10m funding in place to maintain significant pace of growth across the Group Consolidated group revenue increased by 445%
Microtox® PD claims world first live data alerts of SARS-Cov-2 in wastewater treatment plants
Deepverge has announced its intention to raise £10.0 million (gross) through a conditional placing and subscription (the ‘Placing’) of c.33.3 million new ordinary shares with existing and new investors at
New AI centre of excellence in Cork, Ireland to play key role in real-time detection of SARS-CoV-2 in Ireland and across Europe
DeepVerge enters into Memorandum of Understanding (“MoU”) for a Joint Venture with China Resources Environmental Protection Development Limited
Deepverge has announced that its Skin Trust Club iOS App has gone live following the successful completion of 2000 Alpha skin tests.